| 2025 | 2024 | 2023 | 2022 | 2021 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 53,5 k € | -59.4% | 132,0 k € | -9.4% | 145,6 k € | -30.7% | 210,2 k € | -59.5% | 519,7 k € | +37.6% | 377,6 k € | +40.8% | 268,2 k € | +46.4% | 183,2 k € | -58.4% | 440,0 k € | +323.2% | 104,0 k € | -78.4% | 480,9 k € | +27.2% | 378,2 k € | +132.1% | 163,0 k € | +22.7% | 132,8 k € | -45.3% | 242,7 k € | +65.3% | 146,8 k € | -15.7% | 174,2 k € | +973.8% | -19,9 k € | +70.1% | -66,6 k € | |
| EBITDA | -36,0 k € | -166.9% | 53,8 k € | -21.8% | 68,8 k € | -42.9% | 120,4 k € | -59.7% | 298,7 k € | +91.9% | 155,7 k € | +57.2% | 99,0 k € | +196.1% | 33,5 k € | -85.0% | 223,0 k € | +939.2% | -26,6 k € | -71.5% | -15,5 k € | -105.8% | 266,0 k € | +298.0% | 66,8 k € | +756.4% | 7,8 k € | -90.7% | 84,0 k € | +311.7% | -39,7 k € | -223.9% | 32,0 k € | +124.4% | -131,2 k € | +85.2% | -887,4 k € | |
| Operating profit | -89,4 k € | -54965.7% | 163,0 € | -99.7% | 51,2 k € | -52.1% | 106,8 k € | -69.6% | 352,0 k € | +231.1% | 106,3 k € | +421.2% | 20,4 k € | -64.3% | 57,1 k € | -44.1% | 102,2 k € | +414.0% | -32,6 k € | -109.3% | 348,6 k € | +34.1% | 260,0 k € | +411.3% | 50,9 k € | +955.8% | 4,8 k € | -94.0% | 80,8 k € | +717.1% | -13,1 k € | -118.8% | 69,8 k € | +151.0% | -136,9 k € | +28.6% | -191,7 k € | |
| Profit/loss | -96,3 k € | -760.9% | -11,2 k € | -196.7% | 11,6 k € | -77.0% | 50,4 k € | -79.6% | 247,3 k € | +198.6% | 82,8 k € | +509.3% | -20,2 k € | -192.3% | 21,9 k € | -69.4% | 71,6 k € | +554.9% | 10,9 k € | -96.7% | 334,0 k € | +55.0% | 215,6 k € | +3407.3% | -6,5 k € | +90.7% | -70,0 k € | -614.6% | 13,6 k € | -87.9% | 112,8 k € | -74.4% | 440,1 k € | +424.0% | -135,8 k € | -118.1% | 751,8 k € | |
| Equity | 69,9 k € | -58.0% | 166,2 k € | -6.3% | 177,4 k € | +5.3% | 168,4 k € | +38.9% | 121,2 k € | +148.6% | -249,5 k € | +22.9% | -323,8 k € | -6.7% | -303,6 k € | +6.7% | -325,5 k € | +18.0% | -397,1 k € | +2.7% | -408,1 k € | +45.0% | -742,1 k € | +22.5% | -957,6 k € | -0.7% | -951,1 k € | -7.9% | -881,2 k € | +1.5% | -894,8 k € | +11.2% | -1,0 M € | +30.4% | -1,4 M € | -10.4% | -1,3 M € | |
| Total assets | 102,5 k € | -83.5% | 621,5 k € | -50.5% | 1,3 M € | +77.6% | 707,3 k € | -31.8% | 1,0 M € | -3.5% | 1,1 M € | -35.8% | 1,7 M € | -15.3% | 2,0 M € | +10.9% | 1,8 M € | -1.6% | 1,8 M € | -12.2% | 2,1 M € | +78.6% | 1,2 M € | -14.3% | 1,3 M € | +22.8% | 1,1 M € | +103.4% | 539,9 k € | -9.0% | 593,0 k € | -17.4% | 718,4 k € | +32.2% | 543,3 k € | -16.3% | 648,8 k € | |
| Cash | 19,3 k € | -57.0% | 44,8 k € | -91.0% | 498,9 k € | +6090.2% | 8,1 k € | -89.2% | 74,6 k € | +16.2% | 64,2 k € | -60.7% | 163,5 k € | -20.2% | 204,9 k € | -21.1% | 259,8 k € | +207.6% | 84,4 k € | -39.8% | 140,2 k € | +38.0% | 101,6 k € | -63.1% | 275,1 k € | +411.1% | 53,8 k € | -52.2% | 112,7 k € | -9.0% | 123,8 k € | +54.1% | 80,3 k € | +217.5% | 25,3 k € | +1888.8% | 1,3 k € | |
| Debts | 32,6 k € | -92.8% | 455,3 k € | -57.8% | 1,1 M € | +102.0% | 533,8 k € | -41.7% | 916,4 k € | -30.8% | 1,3 M € | -29.4% | 1,9 M € | -16.2% | 2,2 M € | +8.1% | 2,1 M € | -6.2% | 2,2 M € | -10.5% | 2,5 M € | +30.0% | 1,9 M € | -17.7% | 2,3 M € | +12.6% | 2,0 M € | +44.2% | 1,4 M € | -0.0% | 1,4 M € | -14.1% | 1,7 M € | -16.5% | 2,0 M € | +1.6% | 2,0 M € | |
| Staff | 0,8 | 0,8 | 0,8 | 1 | 1,7 | 2 | 1,9 | 2 | 2,3 | 1,5 | 1,7 | 1,5 | 2,3 | 2,5 | 2,5 | 3,3 | 3 | 2,5 | 2,4 | |||||||||||||||||||
Public limited company · Kontich · incorporated on 25/04/1995 · 0,8 ETP
Company — End of the moratorium.
Public limited company loss-making in the latest fiscal year. Cash position declining (-57.0%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
PHARMACEUTICAL ENTERPRISES BELGIUM is a Public limited company incorporated in 1995. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Kontich. It employs on average 0,8 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette